Virtu Financial LLC Purchases Shares of 53,394 Medline $MDLN

Virtu Financial LLC acquired a new position in Medline (NASDAQ:MDLN) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 53,394 shares of the company’s stock, valued at approximately $2,243,000.

Several other hedge funds and other institutional investors have also modified their holdings of MDLN. Sound Income Strategies LLC purchased a new stake in shares of Medline during the 4th quarter worth about $25,000. Entrust Financial LLC purchased a new position in Medline in the fourth quarter valued at approximately $26,000. NBC Securities Inc. acquired a new position in Medline during the fourth quarter valued at approximately $28,000. Global Retirement Partners LLC acquired a new position in Medline during the fourth quarter valued at approximately $31,000. Finally, North Star Investment Management Corp. purchased a new stake in Medline during the fourth quarter worth approximately $36,000.

Insider Buying and Selling at Medline

In other news, insider Jessi L. Corcoran acquired 5,000 shares of the firm’s stock in a transaction on Friday, June 5th. The stock was bought at an average cost of $34.15 per share, with a total value of $170,750.00. Following the transaction, the insider directly owned 5,000 shares in the company, valued at approximately $170,750. This represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Douglas P. Golwas sold 100,000 shares of the firm’s stock in a transaction dated Tuesday, June 16th. The shares were sold at an average price of $36.77, for a total value of $3,677,000.00. Following the sale, the insider owned 23,899 shares of the company’s stock, valued at $878,766.23. This represents a 80.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.81% of the company’s stock.

Medline Price Performance

Shares of NASDAQ:MDLN opened at $35.94 on Friday. The company has a debt-to-equity ratio of 0.65, a current ratio of 4.41 and a quick ratio of 2.51. Medline has a 52-week low of $32.81 and a 52-week high of $50.88. The firm has a 50 day moving average price of $40.02. The firm has a market capitalization of $47.21 billion and a P/E ratio of 112.31.

Medline (NASDAQ:MDLN) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.04. The firm had revenue of $7.35 billion for the quarter. The business’s revenue for the quarter was up 10.7% on a year-over-year basis. On average, equities analysts anticipate that Medline will post 1.49 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on MDLN shares. BNP Paribas Exane dropped their price objective on shares of Medline from $49.00 to $40.00 and set a “neutral” rating for the company in a research report on Thursday, May 14th. BTIG Research reaffirmed a “buy” rating and set a $55.00 price target on shares of Medline in a research report on Thursday, May 7th. William Blair reiterated an “outperform” rating on shares of Medline in a report on Thursday, June 4th. Robert W. Baird lowered their price target on Medline from $57.00 to $45.00 and set an “outperform” rating for the company in a report on Wednesday, June 3rd. Finally, Evercore reissued an “outperform” rating and issued a $55.00 price objective on shares of Medline in a research report on Wednesday, February 25th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $50.54.

Medline Company Profile

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.